Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meridia in obese adolescents
NCT00261911Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2000
01
Overview
Phase 3, randomised, double-blind trial of sibutramine in obesity, sponsored by Abbott Laboratories. Started Jul 2000; status: completed.
02
Drugs
sibutramine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00261911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261911.